FDA Approval and First Implant of Orsiro Mission Drug-Eluting Stent System in the U.S.

Share this story

Full Commercial Launch Underway for One of the Most Studied and Thinnest Strut Drug-Eluting Stents, Offering Enhanced Deliverability

Leave a Comment

Your email address will not be published.

*